Beijing targets strategic nations, regions with vaccine access but it comes with strings attached, unanswered questions
A worker tests an experimental vaccine for the COVID-19 at the Sinovac Biotech facilities in Beijing on April 29, 2020. Nicolas Asfouri/AFP via Getty Images
Is China leveraging its pandemic in new ways? It appears that Beijing is taking a page out of its Belt and Road Initiative (BRI) debt-trap strategy and applying it to countries victimized by the CCP virus (novel coronavirus).
James Gorrie
Author
James R. Gorrie is the author of “The China Crisis” (Wiley, 2013) and writes on his blog, TheBananaRepublican.com. He is based in Southern California.